• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Israel News

#Israel: Israel in social media

  • About
  • Support Us
  • Tech Jobs
  • Contact

Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide

March 19, 2020 By admin

Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month

TEL AVIV, Israel & PARSIPPANY, N.J. – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals across the U.S. to meet the urgent demand for the medicine as an investigational target to treat COVID-19. The company is also looking at additional ways to address the global need.

“We are committed to helping to supply as many tablets as possible as demand for this treatment accelerates at no cost,” said Brendan O’Grady, Teva Executive Vice President, North America Commercial. “Immediately upon learning of the potential benefit of hyroxychloroquine, Teva began to assess supply and to urgently acquire additional ingredients to make more product while arranging for all of what we had to be distributed immediately.”

Additional production of hydroxychloroquine sulfate tablets is also being assessed and subsequently ramped up with materials that are being sent to Teva from our ingredient supplier. Teva will ship 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month.

Hydroxychloroquine sulfate tablets manufactured by Teva are approved by U.S. Food and Drug Administration (FDA) for the treatment of malaria, lupus erythematosus and rheumatoid arthritis. Although the product is not currently approved for use in the treatment of COVID-19, it is currently under investigation for efficacy against the coronavirus and has been requested by US government officials to be made available for use immediately. The Company is also reviewing supply of both hydroxychloroquine and chloroquine globally to determine whether there are additional supply and access opportunities for patients.

Teva is also actively looking across its expansive range of products to determine if the company can help to provide any other products that may be relevant in addressing acute and substantial need during the COVID-19 crisis.

Source: Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)
www.tevapharm.com

Filed Under: Featured Posts Tagged With: Covid-19

Footer

Recent Posts

  • A Swarm of the Sea: Jellyfish Blanket Israel’s Coastline from Ashkelon to Haifa
  • Haifa’s Real Estate: A Bubble on the Brink
  • The Proliferation of Ring-Necked Parakeets in Israel: A Complex Ecological Challenge
  • Voyantis Redefines Growth Strategy with $41M Funding Round Led by Intel Capital
  • A pogrom in the streets of Amsterdam
  • WITH ANTISEMITISM AT AN ALL-TIME HIGH, JUST AHEAD OF KRISTALLNACHT, IMMERSIVE XR EXPERIENCE LAUNCHES, GIVING VIEWERS UNPRECEDENTED LOOK INSIDE A PIVOTAL MOMENT IN THE HOLOCAUST
  • UN chief Antonio Guterres just now mourned a mass murderer who oversaw the kidnapping of Hersh Goldberg-Polin
  • Good Morning from Haifa!
  • Haifa’s Empty Beaches Amid Ongoing Conflict with Hezbollah
  • Gloryless Fall of Sinwar: From Hiding to Oblivion

Media Partners

  • Cybersecurity Market
  • Media Partners
Link11 brings three brands together on one platform with new branding
Octane Raises $6.75 Million to Bolster Blockchain Security with AI
CyberShark Pitch Competition Reveals First Finalists, Elevating Innovations in Cybersecurity
CyberSheath Achieves CMMC Level 2 Certification, Strengthening Its Leadership in Defense Compliance
IonQ Acquires Lightsynq to Push Toward Modular Quantum Networks and the Quantum Internet
CyberArk Advances Identity Security with Comprehensive Solutions for Human, AI, and Machine Identities
Cyber’s Leading Minds Take the Stage at Black Hat USA 2025
General Dan Caine Headlines Cybersecurity Gathering in Washington Amid Rising Threat Landscape
Cisco Fuses AI Security Into the Network Fabric: A Unified Vision for the Agentic Era
Catalonia’s Digital Fortification: Barcelona Cybersecurity Congress to Spotlight Industrial Defense
Bootstrapping
Opinion
Brands to Shop
Briefly
DN4B
Travel MKTG
MKTG Dev
Domain Aftermarket
Side Hustle Art
Media Instances

Media Partners

  • Defense Market
  • Media Partners
FARNBOROUGH International: Belgium’s Aerospace & Defence companies team up with UK Industry — Booth #1157
Leonardo DRS and BlueHalo Successfully Demonstrate New Counter-UAS Directed Energy Stryker, Shooting Down Drones in Live-Fire Engagement
System High Awarded $49.9 Million Classified IT Destruction Contract
Japan Maritime Self-Defense Force, Missile Defense Agency demonstrate new layered missile defense capability
ASNE Fleet Maintenance & Modernization Symposium, September 17-19, 2024, at the Virginia Beach Convention Center
AeroVironment Secures $288 Million Delivery Order for Switchblade® Loitering Munition Systems Under U.S. Army Contract
goTenna awarded $15M AFWERX STRATFI SBIR Contract for Air Force CoTS Connectivity
Vatn Systems Secures $13M Oversubscribed Seed Round to Revolutionize Naval Warfare
Sentar Awarded $32M Task Order for Defense Health Agency
Navy Awards General Dynamics Bath Iron Works Contract for Three DDG 51 Destroyers
DN4B
Timey
Defense Market
API Coding
Game Tech Market
Media Presser
Side Hustle Art
MSL
Technologies
ESN

Copyright © 2015 IsraelNews.org

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT